Valence Advantage Life Sciences Fund II, L.P.
New york, Ny
Valence Advantage Life Sciences Fund II, L.P. is a venture capital fund managed by Valence Advantage Life Sciences. Its SEC Form D filing reports a $175.0M target and an SEC filing on March 14, 2012.
Amount Raised
—
Target Size
$175.0M
Investors
0
Date Filed
2012-03-14
Filing history
| Type | Filed | Amount | Accession | SEC |
|---|---|---|---|---|
| Original(this) | 2012-03-14 | — | 0001544406-12-000001 | ↗ |
| Amendment | 2013-03-14 | $60.8M | 0001544406-13-000001 | ↗ |
Filing details
Fund vehicleValence Advantage Life Sciences Fund II, L.P.
IndustryVenture Capital Fund
Address500 PARK AVENUE, 9TH FLOOR, NEW YORK, NY
Phone212-891-1100
Accession #0001544406-12-000001
Related personsView on SEC EDGAR ↗